Product Theater: TREMFYA: A Selective IL-23 Inhibitor With Pivotal Studies vs. Adalimumab

from Dermcast · host dermcast.tv

This Product Theater, sponsored by Janssen Biotech, Inc., is from the SDPA Annual Summer Dermatology Conference 2018, held June 27 – July 1, 2018 in Seattle, Washington. Topic: TREMFYA: A Selective IL-23 Inhibitor With Pivotal Studies vs. Adalimumab Faculty: Cynthia Trickett, MPAS, PA-C, DFAAPA

Episode metadata supplied by the publisher feed · Published Jan 23, 2019

Embed this episode

Attribution link and audio player

Ready to play

Product Theater: TREMFYA: A Selective IL-23 Inhibitor With Pivotal Studies vs. Adalimumab

0:00 0:00

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

Dermcast - part of the DermPA Network Society of Dermatology Physician Associates Dermcast is the official online media resource of the DermPA Network and Society of Dermatology Physician Associates (SDPA). The site hosts recorded interviews and round table discussions featuring renowned dermatologists and DermPAs who provide real-world information on diagnosing, treating and managing dermatology patients. Some examples of topics covered in the content include trends, best practices and updated details on a variety of disease states including acne, psoriasis, eczema, atopic dermatitis, skin cancer and a variety of other common and rare dermatologic diseases.

Frequently Asked Questions

When was this Dermcast episode published?

This episode was published on January 23, 2019.

Can I download this Dermcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!